Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.049
Neutral
RSI(14)
46.927
Neutral
STOCH(KDJ)(9,3,3)
49.768
Sell
ATR(14)
0.116
High Vlolatility
CCI(14)
-1.856
Neutral
Williams %R
49.351
Neutral
TRIX(12,20)
-0.332
Sell
StochRSI(14)
0.000
Sell
Clover Health Investments Corp
CLOV2.620USD
-0.010-0.38%
Close 08/29, 16:00（ET）Quotes delayed by 15 min
1.34BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Currency: USD Updated：2025-08-29Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
3.270
Target Price
+24.81%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Clover Health Investments, Corp. is a physician-enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a health equity-based focus on seniors, who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. For healthcare providers outside its MA plan, it focuses on extending the benefits of its data-driven technology platform to a wider audience via its subsidiary, Counterpart Health, Inc.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.04% year-on-year.
Overvalued
The company’s latest PE is -30.14, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 137.98M shares, increasing 11.57% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 24.15M shares of this stock.
Financial Health
Currency: USD Updated：2025-08-29The company's current financial score is 8.31, which is higher than the Healthcare Services & Equipment industry's average of 7.15. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 462.33M, representing a year-over-year increase of 33.27%, while its net profit experienced a year-over-year increase of 93.35%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data
Quality of Earnings
10.00
Operational Efficiency
7.46
Growth Potential
6.95
Shareholder Returns
7.15
Company Valuation
Currency: USD Updated：2025-08-29The company’s current valuation score is 1.20, which is lower than the Healthcare Services & Equipment industry's average of 2.15. Its current P/E ratio is -30.94, which is 11.52% below the recent high of -34.51 and -112.31% above the recent low of -65.69.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 108/280
No Data
Earnings Forecast
Currency: USD Updated：2025-08-29The company’s current earnings forecast score is 6.80, which is lower than the Healthcare Services & Equipment industry's average of 7.66. The average price target for Clover Health Investments Corp is 3.00, with a high of 5.00 and a low of 1.75.
Score
Support & Resistance
No Data
Analyst Rating
Based on
4
analysts
Buy
Current Rating
3.270
Target Price
+24.81%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
9
Total
21
Median
19
Average
Company name
Ratings
Analysts
Clover Health Investments Corp
CLOV
4
UnitedHealth Group Inc
UNH
28
Humana Inc
HUM
27
Cigna Group
CI
26
Elevance Health Inc
ELV
24
Centene Corp
CNC
21
1
2
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
No Data
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated：2025-08-29The company’s current price momentum score is 9.06, which is higher than the Healthcare Services & Equipment industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 3.09 and the support level at 2.21, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.651
Sell
MA10
2.627
Sell
MA20
2.573
Buy
MA50
2.789
Sell
MA100
3.063
Sell
MA200
3.393
Sell
Institutional Confidence
Currency: USD Updated：2025-08-29The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Services & Equipment industry's average of 7.19. The latest institutional shareholding proportion is 32.99%, representing a quarter-over-quarter increase of 9.94%. The largest institutional shareholder is The Vanguard, holding a total of 24.15M shares, representing 5.75% of shares outstanding, with 22.18% increase in holdings.
Score
Institutional Shareholding
No Data
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Geode Capital Management, L.L.C.
State Street Global Advisors (US)
PNC Investments LLC
Charles Schwab Investment Management, Inc.
Citadel Advisors LLC
Marshall Wace LLP
1
2
Risk Assessment
Currency: USD Updated：2025-08-29The company's beta value is 1.98. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.97
VaR
+7.27%
240-Day Maximum Drawdown
+54.77%
240-Day Volatility
+73.12%
Return
Best Daily Return
60 days
+13.30%
120 days
+13.30%
5 years
+85.82%
Worst Daily Return
60 days
-20.70%
120 days
-20.70%
5 years
-23.61%
Sharpe Ratio
60 days
-0.54
120 days
-0.69
5 years
+0.11
Risk Assessment
Maximum Drawdown
240 days
+54.77%
3 years
+60.90%
5 years
+97.19%
Return-to-Drawdown Ratio
240 days
-0.23
3 years
+0.40
5 years
-0.15
Skewness
240 days
+0.96
3 years
+0.80
5 years
+3.28
Volatility
Realised Volatility
240 days
+73.12%
5 years
+89.50%
Standardised True Range
240 days
+7.90%
5 years
+12.07%
Downside Risk-Adjusted Return
120 days
-95.54%
240 days
-95.54%
Maximum Daily Upside Volatility
60 days
+69.75%
Maximum Daily Downside Volatility
60 days
+63.72%
Liquidity
Average Turnover Rate
60 days
+1.81%
120 days
+1.50%
5 years
--
Turnover Deviation
20 days
+6.43%
60 days
+22.45%
120 days
+1.06%
Peer Comparison
Currency: USD Updated：2025-08-29Clover Health Investments Corp
CLOV
6.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
PODD
7.89 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Merit Medical Systems Inc
MMSI
7.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tenet Healthcare Corp
THC
7.66 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
7.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
The Stock Score data is powered by TradingKey and updated daily. Rating data is sourced from LESG. Please use the data with caution for reference purposes only.
